• Blanco MA, Aleckovic M, Hua Y, Li T, Wei Y, Xu Z, Cristea IM, Kang Y. 2011. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J Biol Chem 286:1998219992.
  • Callebaut I, Mornon JP. 1997. The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development. Biochem J 321:125132.
  • Caudy AA, Ketting RF, Hammond SM, Denli AM, Bathoorn AM, Tops BB, Silva JM, Myers MM, Hannon GJ, Plasterk RH. 2003. A micrococcal nuclease homologue in RNAi effector complexes. Nature 425:411414.
  • Dash AB, Orrico FC, Ness SA. 1996. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev 10:18581869.
  • Gao X, Ge L, Shao J, Su C, Zhao H, Saarikettu J, Yao X, Yao Z, Silvennoinen O, Yang J. 2010. Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Lett 584:35253532.
  • Gao X, Zhao X, Zhu Y, He J, Shao J, Su C, Zhang Y, Zhang W, Saarikettu J, Silvennoinen O, Yao Z, Yang J. 2012. Tudor staphylococcal nuclease (Tudor-SN) participates in small ribonucleoprotein (snRNP) assembly via interacting with symmetrically dimethylated Sm proteins. J Biol Chem 287:1813018141.
  • Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, Wong CH, Wong CY, Shah N, Lim YP. 2009. Novel breast cancer metastasis-associated proteins. J Proteome Res 8:583594.
  • Huynh H, Chow PK, Ooi LL, Soo KC. 2002. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Cell Growth Differ 13:115122.
  • Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. 2000. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215244.
  • Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N, Egawa S. 2009. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer. Am J Pathol 174:20442050.
  • Leverson JD, Koskinen PJ, Orrico FC, Rainio EM, Jalkanen KJ, Dash AB, Eisenman RN, Ness SA. 1998. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell 2:417425.
  • Li CL, Yang WZ, Chen YP, Yuan HS. 2008. Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing. Nucleic Acids Res 36:35793589.
  • Shaw N, Zhao M, Cheng C, Xu H, Saarikettu J, Li Y, Da Y, Yao Z, Silvennoinen O, Yang J, Liu ZJ, Wang BC, Rao Z. 2007. The multifunctional human p100 protein ‘hooks’ methylated ligands. Nat Struct Mol Biol 14:779784.
  • Tong X, Drapkin R, Yalamanchili R, Mosialos G, Kieff E. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol Cell Biol 15:47354744.
  • Tsuchiya N, Nakagama H. 2010. MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis. Mutat Res 693:94100.
  • Tsuchiya N, Ochiai M, Nakashima K, Ubagai T, Sugimura T, Nakagama H. 2007. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res 67:95689576.
  • Wang X, Liu X, Fang J, Lu Y, He J, Yao X, Yao Z, Yang J. 2010. Coactivator P100 protein enhances STAT6-dependent transcriptional activation but has no effect on STAT1-mediated gene transcription. Anat Rec (Hoboken) 293:10101016.
  • Wu J, Zhu AX. 2011. Targeting insulin-like growth factor axis in hepatocellular carcinoma. J Hematol Oncol 4:30.
  • Yang J, Valineva T, Hong J, Bu T, Yao Z, Jensen ON, Frilander MJ, Silvennoinen O. 2007. Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids Res 35:44854494.
  • Yoo BK, Santhekadur PK, Gredler R, Chen D, Emdad L, Bhutia S, Pannell L, Fisher PB, Sarkar D. 2011. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 53:15381548.